-Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model

Press/Media: Expert Comment

PeriodMar 16 2021

Media coverage

2

Media coverage

  • Title-Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
    Media name/outletENP Newswire
    Date3/16/21
    PersonsChien-Te Tseng
  • Title-Adamis Pharmaceuticals Announces Tempol Reduces Lung Inflammation in the COVID-19 Challenged Hamster Model
    Media name/outletENP Newswire
    Date3/16/21
    PersonsChien-Te Tseng
View all 2
View less

Keywords

  • COVID-19